{"id":"W4410646356","doi":"10.51731/cjht.2025.1133","title":"Durvalumab (Imfinzi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002941228,0.0002632218,0.0004102695,0.0003396685,0.0002461491,0.0005898229,0.0004639502,0.0004833259,0.008992268],"category_scores_gemma":[0.0004658572,0.00008906802,0.0002770432,0.0002639785,0.0001552209,0.0003481363,0.0002844634,0.001313632,0.003453614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002025403,"about_ca_system_score_gemma":0.001040233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00690615,"about_ca_topic_score_gemma":0.02562393,"domain_scores_codex":[0.9998531,0.00001402045,0.000009752705,0.00002278545,0.00006054233,0.00003969123],"domain_scores_gemma":[0.9998821,0.00001512426,0.00002205853,0.000008985833,0.00002112014,0.00005061195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003075633,0.0004584531,0.00350791,0.0006787349,0.0001663591,0.0009388097,0.00007894213,0.0006276819,0.01922262,0.004575579,0.1158871,0.8507822],"study_design_scores_gemma":[0.005584506,0.001654421,0.01257272,0.0003764936,0.0002089432,0.006108979,0.00005719379,0.001233882,0.01648374,0.001803913,0.9538825,0.0000327231],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.2568421,0.2792705,0.008023955,0.02303013,0.002755197,0.001265586,0.01288976,0.002794733,0.413128],"genre_scores_gemma":[0.773934,0.04826107,0.009352316,0.00998119,0.0005421983,0.0005695433,0.01270008,0.0001540233,0.1445055],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.008992268,"threshold_uncertainty_score":0.03008211,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0205969704681081,"score_gpt":0.3100979731477825,"score_spread":0.2895010026796744,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}